Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec;27(8):e14605.
doi: 10.1111/petr.14605. Epub 2023 Sep 11.

Clinical course of post-kidney transplant Schimke immuno-osseous dysplasia

Hyun Ah Woo  1 , Seong Heon Kim  1 , Yo Han Ahn  1 , Sang Il Min  2 , Jongwon Ha  2 , Il-Soo Ha  1 , Hae Il Cheong  1 , Hee Gyung Kang  1   3
Affiliations
Case Reports

Clinical course of post-kidney transplant Schimke immuno-osseous dysplasia

Hyun Ah Woo et al. Pediatr Transplant. 2023 Dec.

Abstract

Background: Schimke immuno-osseous dysplasia (SIOD) is a rare systemic disease characterized by short stature, proteinuria, and recurrent infections. Patients usually have spondyloepiphyseal dysplasia, and progressive steroid-resistant nephropathy that leads to kidney failure. However, their clinical course after kidney transplantation (KT) is not yet well known. Here, we present our experience with cases of SIOD treated at our institute.

Case presentation: Since 2014, three children have been diagnosed with nephropathy resulting from SIOD. They presented with proteinuria in the nephrotic range at 7, 5, and 3 years of age. Focal segmental glomerulosclerosis was confirmed and progressed to kidney failure approximately 2 years after proteinuria was detected. These patients underwent living-donor KT from their parents. After KT, Case 1 lost his graft within 7 months due to multi-organ failure caused by disseminated adenovirus infection and died. Case 2 experienced graft failure 5 years after KT due to acute rejection from poor compliance. In Case 3, the allograft was still functioning 6 years after KT with low-dose tacrolimus single medication (trough level < 5 ng/mL). Extra-renal manifestations progressed regardless of KT, namely, right renal vein thrombosis and pulmonary hypertension in Case 1, severe bilateral hip dysplasia and Moyamoya syndrome in Case 2, and neutropenia and thrombocytopenia in Case 3, in addition to recurrent infection.

Conclusion: In SIOD patients, KT is complicated with recurrent infections due to their inherent immune dysfunction. Additionally, extra-renal symptoms may render the patients morbid despite the recovery of kidney function.

Keywords: Schimke immuno-osseous dysplasia; extra-renal; kidney failure; kidney transplantation.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Schimke RN, Horton WA, King CR. Chondroitin-6-sulphaturia, defective cellular immunity, and nephrotic syndrome. Lancet. 1971;2(7733):1088-1089.
    1. Morimoto M, Lewis DB, Lucke T, Boerkoel CF. Schimke immunoosseous dysplasia. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews((R)). University of Washington; 1993.
    1. Lipska-Zietkiewicz BS, Gellermann J, Boyer O, et al. Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia. PLoS ONE. 2017;12(8):e0180926.
    1. Boerkoel CF, Takashima H, John J, et al. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet. 2002;30(2):215-220.
    1. Bansbach CE, Boerkoel CF, Cortez D. SMARCAL1 and replication stress: an explanation for SIOD? Nucleus. 2010;1(3):245-248.

Publication types

Supplementary concepts

LinkOut - more resources